Adherence to a guided walking program with amelioration of cognitive functions in subjects with schizophrenia even during COVID-19 pandemic.
Cardiovascular risk factors
Mental disorder
Physical activity
Schizophrenia
Journal
BMC sports science, medicine & rehabilitation
ISSN: 2052-1847
Titre abrégé: BMC Sports Sci Med Rehabil
Pays: England
ID NLM: 101605016
Informations de publication
Date de publication:
25 Mar 2022
25 Mar 2022
Historique:
received:
26
04
2021
accepted:
15
03
2022
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
27
3
2022
Statut:
epublish
Résumé
Aim of the study was to enrol a group of individuals with schizophrenia in a long-term moderate-intensity physical activity program and to evaluate its effects on their cognitive functions and cardiovascular risk factors. An additional aim of the study was the comparison of the adherence to the physical activity program before and during the COVID-19 pandemic. Forty sedentary patients diagnosed with schizophrenia (mean age 46.4 ± 9.6) followed by the Public Mental Health Department of Ferrara were included in the study. 28 of them followed a 1-year walking program consisting of two guided walking sessions/week, while 12 maintained their sedentary lifestyle and followed the usual Cognitive Rehabilitation program. To the participants following the walking program VO The 20 participants completing the walking program displayed significant improvements in cognitive functions (d The main finding of this study is the improvement of cognitive functions which is significantly related to the number of walking sessions attended by participants with schizophrenia. The walking program, guided by exercise specialists, proved to be an enjoyable activity for people with mental disorder feasible even during the COVID-19 pandemic. Trial registration Retrospectively registered on ISRCTN as non-randomized trial (n. ISRCTN14763786).
Sections du résumé
BACKGROUND
BACKGROUND
Aim of the study was to enrol a group of individuals with schizophrenia in a long-term moderate-intensity physical activity program and to evaluate its effects on their cognitive functions and cardiovascular risk factors. An additional aim of the study was the comparison of the adherence to the physical activity program before and during the COVID-19 pandemic.
METHODS
METHODS
Forty sedentary patients diagnosed with schizophrenia (mean age 46.4 ± 9.6) followed by the Public Mental Health Department of Ferrara were included in the study. 28 of them followed a 1-year walking program consisting of two guided walking sessions/week, while 12 maintained their sedentary lifestyle and followed the usual Cognitive Rehabilitation program. To the participants following the walking program VO
RESULTS
RESULTS
The 20 participants completing the walking program displayed significant improvements in cognitive functions (d
CONCLUSIONS
CONCLUSIONS
The main finding of this study is the improvement of cognitive functions which is significantly related to the number of walking sessions attended by participants with schizophrenia. The walking program, guided by exercise specialists, proved to be an enjoyable activity for people with mental disorder feasible even during the COVID-19 pandemic. Trial registration Retrospectively registered on ISRCTN as non-randomized trial (n. ISRCTN14763786).
Identifiants
pubmed: 35337370
doi: 10.1186/s13102-022-00440-2
pii: 10.1186/s13102-022-00440-2
pmc: PMC8951652
doi:
Types de publication
Journal Article
Langues
eng
Pagination
48Informations de copyright
© 2022. The Author(s).
Références
Schizophr Res. 2016 Mar;171(1-3):103-9
pubmed: 26805414
J Psychiatr Res. 2016 Apr;75:91-106
pubmed: 26828372
Schizophr Res. 2020 Apr;218:188-194
pubmed: 31948897
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342
Schizophr Res. 2014 Sep;158(1-3):156-62
pubmed: 25086658
PeerJ. 2018 Aug 30;6:e5471
pubmed: 30186685
Schizophr Res. 2015 Oct;168(1-2):213-22
pubmed: 26305063
J Psychopharmacol. 2010 Nov;24(4 Suppl):17-25
pubmed: 20923917
J Sports Med Phys Fitness. 2018 Sep;58(9):1312-1317
pubmed: 28967238
Psychiatry Res. 2010 May 30;177(3):271-9
pubmed: 20406713
J Sports Med Phys Fitness. 2020 May;60(5):786-793
pubmed: 32438791
J Psychopharmacol. 2019 Apr;33(4):436-448
pubmed: 30730250
J Psychopharmacol. 2010 Nov;24(4 Suppl):9-15
pubmed: 20923916
World Psychiatry. 2017 Oct;16(3):308-315
pubmed: 28941119
Arch Med Res. 2012 Nov;43(8):615-21
pubmed: 23085449
Disabil Rehabil. 2012;34(1):1-12
pubmed: 21957908
J Clin Psychiatry. 2014 Sep;75(9):964-74
pubmed: 24813261
Can J Psychiatry. 2010 Dec;55(12):752-60
pubmed: 21172095
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
J Cardiopulm Rehabil Prev. 2012 Sep-Oct;32(5):262-9
pubmed: 22936157
Sci Rep. 2020 Feb 26;10(1):3472
pubmed: 32103064
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Early Interv Psychiatry. 2018 Jun;12(3):307-315
pubmed: 26987871
Schizophr Bull. 2017 May 1;43(3):546-556
pubmed: 27521348
J Psychopharmacol. 2010 Nov;24(4 Suppl):37-50
pubmed: 20923919
JAMA Psychiatry. 2021 Apr 1;78(4):380-386
pubmed: 33502436
Sports Med. 1997 May;23(5):306-32
pubmed: 9181668
Lancet Psychiatry. 2018 Sep;5(9):739-746
pubmed: 30099000
Biol Sport. 2021 Oct;38(4):495-506
pubmed: 34937958
Int J Environ Res Public Health. 2021 Apr 19;18(8):
pubmed: 33921852
Community Ment Health J. 2020 Nov;56(8):1411-1418
pubmed: 32076904
Schizophr Bull. 2018 Oct 17;44(6):1293-1300
pubmed: 29069474
J Hum Hypertens. 2021 Mar;35(3):226-231
pubmed: 32152454
Int J Cardiol. 2014 May 1;173(2):248-52
pubmed: 24630380
Schizophr Res. 2016 Apr;172(1-3):213-5
pubmed: 26852401
Schizophr Res. 2018 Nov;201:98-104
pubmed: 29861267
BMJ Open. 2013 Oct 25;3(10):e003446
pubmed: 24163203
Am J Psychiatry. 2011 May;168(5):472-85
pubmed: 21406461
Psychol Med. 2017 Apr;47(6):1030-1040
pubmed: 28032535